NATCO Pharma Share Price Target 2025 – Nirmal Bang: Shares of NATCO Pharma have come under the spotlight due to fluctuations in the stock market. Nirmal Bang has maintained a ‘Hold’ rating for the company and revised its target price to Rs 1,044. This follows the company’s struggles in Q3, where both revenues and margins sharply declined, largely due to the absence of Revlimid sales in the U.S. and a slowdown in its domestic business.
NATCO Pharma Share Price Today
On 2025, NATCO Pharma shares were trading 1.25% lower at Rs 872.20 on the NSE, compared to the last closing price of Rs 883.20. The shares traded within a price range of Rs 861.90 – Rs 903.15. The total trading volume for the day was 1,060,252 shares. The stock has recorded a 52-week high of Rs 1,639.00 and a 52-week low of Rs 861.90.
NATCO Pharma Share Price Target 2025 – Nirmal Bang’s Analysis
Nirmal Bang has set a ‘Hold’ rating on NATCO Pharma, with a price target of Rs 1,044, representing a 20% upside from the current market price. Despite a tough quarter, analysts remain cautious about the stock due to the company’s dependency on the performance of Revlimid and CTPR. The lack of strong growth drivers in both the U.S. market and the domestic market has contributed to this cautious outlook.
For Q3, the company saw a sharp decline in performance, with revenue falling 38% due to the absence of Revlimid sales in the U.S. The domestic formulations business also experienced a decline. EBITDA dropped 86%, and margins shrank 27%, mainly due to rising R&D expenses. Given these challenges, Nirmal Bang recommends holding the stock.
NATCO Pharma Stock Overview
| Metric | Value |
| Previous Close (Rs) | 883.20 |
| Market Cap (Rs Bn) | 156.514 |
| Open (Rs) | 880.00 |
| Beta (5Yr Monthly) | 0.55 |
| PE Ratio (TTM) | 8.39 |
| EPS (TTM) | 104.13 |
| Day Range (Rs) | 861.90 – 903.15 |
| Earnings Date | Feb 12, 2025 |
| 52 Week Range (Rs) | 861.90 – 1,639.00 |
| Dividend & Yield | 7.25 (0.82%) |
| Volume (Shares) | 1,060,252 |
| Ex-Dividend Date | Feb 18, 2025 |
| Avg. Volume (Shares) | 769,974 |
| 1-Year Target Est (Rs) | 1,153.17 |
Category: Market News
NATCO Pharma Performance Overview
| Time Period | NATCOPHARM Return (%) | S&P BSE SENSEX Return (%) |
| YTD Return | -37.05% | -3.14% |
| 1-Year Return | -14.56% | +4.50% |
| 3-Year Return | +1.51% | +30.73% |
| 5-Year Return | +36.67% | +84.35% |
Conclusion: A Cautious Outlook for NATCO Pharma
Nirmal Bang’s cautious stance on NATCO Pharma reflects the company’s current challenges in both domestic and international markets. Despite the revised target price of Rs 1,044, the stock’s performance heavily relies on the revival of Revlimid sales and strong performance in the U.S. market. Investors are advised to hold their positions until clearer growth prospects emerge.
NATCO Pharma Share Price Target from 2025 to 2030
Here is a table summarizing yearly price target of NATCO Pharma share from 2025 to 2030.
|
Year |
Price Target |
Percent Increase |
|
2025 |
₹1,244.90 |
52.04% |
|
2026 |
₹1,508.71 |
84.26% |
|
2027 |
₹1,711.50 |
109.03% |
|
2028 |
₹1,964.93 |
139.98% |
|
2029 |
₹2,260.60 |
176.09% |
|
2030 |
₹2,542.39 |
210.50% |
Our price forecasting model for analyzing Share targets employs a detailed, data-driven approach to determine monthly price projections. This methodology integrates classic analytical tools, including long-term pivot point analysis, historical performance metrics, and volatility assessment. Below, we outline the key components and processes that constitute our forecasting framework. It is essential to recognize that these price estimates are purely mathematical and should not be considered financial advice. Stock markets are highly dynamic, influenced by multiple unpredictable factors that no single model can comprehensively capture.
Long-Term Pivot Point Analysis
At the core of our methodology lies long-term pivot point analysis, complemented by Fibonacci series calculations. These pivot points help determine critical support and resistance levels, providing a structured framework for anticipating potential price movements.
Pivot = Previous Close
Resistance_n = Pivot + (Range × F_n)
Support_n = Pivot - (Range × F_n)
Where:
- F_n represents Fibonacci multipliers (e.g., 0.382, 0.618, 1.000).
- Range is the difference between the highest and lowest prices over a specific period.
Historical Performance Analysis
A stock's historical performance plays a vital role in predicting its future behavior. Our model conducts an extensive analysis of past data to determine average returns over various timeframes, capturing both short-term fluctuations and long-term trends.
Average Return = (1/N) Σ R_i
Where:
- N is the number of periods (e.g., months or quarters).
- R_i represents the return in the i-th period.
Volatility Assessment
Market volatility is a crucial factor in assessing risk and uncertainty associated with stock price movements. Our methodology incorporates a comprehensive evaluation of stock volatility, measured by the standard deviation of historical returns.
σ = √[(1/(N-1)) Σ (R_i - μ)^2]
Where:
- μ is the mean return.
- R_i is the return in the i-th period.
- N is the total number of returns.
Integrated Predictive Modeling
Our forecasting model integrates pivot point analysis, historical performance, and volatility assessments through advanced predictive techniques, ensuring data-driven and adaptable price projections.
- Calibration Based on Historical Performance: Utilizing past average returns and volatility metrics to align future price targets with the stock’s established patterns.
- Mathematical Optimization: Applying techniques such as the Least Squares Method (LSM) to optimize projections, reducing errors and enhancing forecast precision.
- Dynamic Adjustment: Incorporating real-time market data to refine predictions, ensuring forecasts remain relevant and up-to-date.
Target Price Calibration
The final step in our methodology is the precise calibration of monthly price targets, ensuring they align with analytical insights and market conditions.
Target Price_next month = Current Price × (1 + Adjusted Growth Rate)
Where:
- Adjusted Growth Rate is derived from historical average returns and volatility, refined through our integrated predictive modeling approach.
This ensures that price targets account for both growth potential and associated risks, providing balanced and actionable forecasts.
English
हिंदी